Weiss Ratings Reaffirms "Hold (C-)" Rating for Healthpeak Properties (NYSE:DOC)

Key Points

• Weiss Ratings has reaffirmed a "Hold (C-)" rating for Healthpeak Properties (NYSE:DOC), indicating a cautious outlook on the stock.
• Healthpeak Properties' stock has recently traded at $18.86, showing a 1.5% decline during the latest trading session, with a market capitalization of $13.11 billion.
• Analysts suggest a consensus target price of $21.33, with mixed opinions reflected in various ratings, including eight "Buy" and five "Hold" ratings.

Healthpeak Properties (NYSE:DOC - Get Free Report)'s stock had its "hold (c-)" rating reaffirmed by investment analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

A number of other analysts also recently issued reports on DOC. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Wells Fargo & Company lowered their target price on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 27th. Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the company an "outperform" rating in a research report on Wednesday, July 30th. Morgan Stanley lowered their target price on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a research report on Friday, August 22nd. Finally, Cantor Fitzgerald assumed coverage on Healthpeak Properties in a research report on Wednesday, October 1st. They issued a "neutral" rating and a $20.00 target price on the stock. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and a consensus target price of $21.33.

Healthpeak Properties Stock Down 1.5%

Shares of Healthpeak Properties stock traded down $0.28 during trading on Wednesday, reaching $18.86. The stock had a trading volume of 7,071,388 shares, compared to its average volume of 6,737,135. The company has a market capitalization of $13.11 billion, a price-to-earnings ratio of 78.59, a P/E/G ratio of 3.26 and a beta of 1.09. The stock has a fifty day moving average price of $17.97 and a two-hundred day moving average price of $18.01. Healthpeak Properties has a 52 week low of $16.63 and a 52 week high of $23.26. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts' consensus estimates of $0.46. The company had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The company's quarterly revenue was down .2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Sell-side analysts predict that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Insiders Place Their Bets

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 2,930 shares of the stock in a transaction on Thursday, July 31st. The shares were purchased at an average price of $17.06 per share, with a total value of $49,985.80. Following the completion of the transaction, the chief executive officer directly owned 210,416 shares in the company, valued at $3,589,696.96. This represents a 1.41% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders purchased a total of 8,783 shares of company stock worth $150,129 over the last 90 days. 0.23% of the stock is owned by insiders.

Hedge Funds Weigh In On Healthpeak Properties

Institutional investors and hedge funds have recently made changes to their positions in the company. Brooklyn Investment Group grew its position in shares of Healthpeak Properties by 198.9% in the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 873 shares during the last quarter. TCTC Holdings LLC grew its position in shares of Healthpeak Properties by 124.3% in the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 751 shares during the last quarter. S.A. Mason LLC grew its position in shares of Healthpeak Properties by 160.9% in the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 925 shares during the last quarter. Dagco Inc. acquired a new position in shares of Healthpeak Properties in the first quarter valued at approximately $30,000. Finally, Rexford Capital Inc. acquired a new position in shares of Healthpeak Properties in the second quarter valued at approximately $28,000. Institutional investors and hedge funds own 93.57% of the company's stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.